🇮🇹 LAZERTINIB in Italy

LAZERTINIB (LAZERTINIB) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Lazcluze
  • Status: approved

LAZERTINIB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is LAZERTINIB approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for LAZERTINIB in Italy?

Marketing authorisation holder not available in our data.